HU0800266D0 - Amorphous ritonavir and process for the preparation of the polymorphous form i the same - Google Patents

Amorphous ritonavir and process for the preparation of the polymorphous form i the same

Info

Publication number
HU0800266D0
HU0800266D0 HU0800266A HUP0800266A HU0800266D0 HU 0800266 D0 HU0800266 D0 HU 0800266D0 HU 0800266 A HU0800266 A HU 0800266A HU P0800266 A HUP0800266 A HU P0800266A HU 0800266 D0 HU0800266 D0 HU 0800266D0
Authority
HU
Hungary
Prior art keywords
preparation
same
amorphous ritonavir
polymorphous form
polymorphous
Prior art date
Application number
HU0800266A
Other languages
English (en)
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26817251&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HU0800266(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of HU0800266D0 publication Critical patent/HU0800266D0/hu
Publication of HU230150B1 publication Critical patent/HU230150B1/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
HU0800266A 1998-07-20 1999-07-19 Amorf ritonavir és eljárás előállítására HU230150B1 (hu)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US11934598A 1998-07-20 1998-07-20
US09/119,345 1998-07-20
US32609399A 1999-06-04 1999-06-04
US09/326,093 1999-06-04
PCT/US1999/016334 WO2000004016A2 (en) 1998-07-20 1999-07-19 Polymorph of ritonavir

Publications (2)

Publication Number Publication Date
HU0800266D0 true HU0800266D0 (en) 2008-06-30
HU230150B1 HU230150B1 (hu) 2015-09-28

Family

ID=26817251

Family Applications (3)

Application Number Title Priority Date Filing Date
HU0103823A HU227540B1 (en) 1998-07-20 1999-07-19 Polymorph of ritonavir and process for preparation thereof
HU0800266A HU230150B1 (hu) 1998-07-20 1999-07-19 Amorf ritonavir és eljárás előállítására
HU0800267A HU229999B1 (en) 1998-07-20 1999-07-19 Process for producing the polymorphous form ii of ritonavir

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HU0103823A HU227540B1 (en) 1998-07-20 1999-07-19 Polymorph of ritonavir and process for preparation thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
HU0800267A HU229999B1 (en) 1998-07-20 1999-07-19 Process for producing the polymorphous form ii of ritonavir

Country Status (30)

Country Link
EP (4) EP2017269B1 (hu)
JP (4) JP4815050B2 (hu)
KR (3) KR100740796B1 (hu)
CN (5) CN101966180A (hu)
AR (5) AR019431A1 (hu)
AT (3) ATE261947T1 (hu)
AU (1) AU768207B2 (hu)
BG (4) BG65150B1 (hu)
BR (1) BR9912010A (hu)
CA (3) CA2510949C (hu)
CO (1) CO5090830A1 (hu)
CY (2) CY1111600T1 (hu)
CZ (2) CZ298188B6 (hu)
DE (2) DE69915628T2 (hu)
DK (3) DK1097148T3 (hu)
ES (3) ES2322759T3 (hu)
HK (2) HK1037918A1 (hu)
HU (3) HU227540B1 (hu)
ID (1) ID27996A (hu)
IL (4) IL140492A0 (hu)
MY (2) MY145265A (hu)
NO (2) NO318385B1 (hu)
NZ (2) NZ522690A (hu)
PL (2) PL213978B1 (hu)
PT (3) PT2017269E (hu)
SI (3) SI2017269T1 (hu)
SK (3) SK287381B6 (hu)
TR (1) TR200100171T2 (hu)
TW (3) TWI271400B (hu)
WO (1) WO2000004016A2 (hu)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY145265A (en) * 1998-07-20 2012-01-13 Abbott Lab Amorphous ritonavir
US6894171B1 (en) 1998-07-20 2005-05-17 Abbott Laboratories Polymorph of a pharmaceutical
DK1183026T3 (da) * 1999-06-04 2006-11-06 Abbott Lab Forbedrede farmaceutiske formuleringer omfattende ritonavir
JP2005508294A (ja) * 2001-05-25 2005-03-31 アボット・ラボラトリーズ リトナビルおよび／またはロピナビルを含む軟弾性カプセル
AR037797A1 (es) * 2001-12-12 2004-12-01 Tibotec Pharm Ltd Combinacion de inhibidores de proteasa dependientes del citocromo p450
US7205413B2 (en) 2002-05-03 2007-04-17 Transform Pharmaceuticals, Inc. Solvates and polymorphs of ritonavir and methods of making and using the same
US8377952B2 (en) * 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
BRPI0401742B8 (pt) 2004-05-13 2021-05-25 Cristalia Produtos Quim Farmaceuticos Ltda composto análogo do ritonavir útil como inibidor de protease retroviral, preparação do composto análogo do ritonavir e composição farmacêutica do composto análogo do ritonavir
WO2006129276A1 (en) * 2005-05-30 2006-12-07 Ranbaxy Laboratories Limited Processes for the preparation of stable polymorphic form i of ritonavir
WO2008041176A2 (en) * 2006-10-03 2008-04-10 Ranbaxy Laboratories Limited Process for the preparation of form i and form ii of ritonavir
CN102898398B (zh) * 2011-07-27 2015-01-14 上海迪赛诺药业有限公司 一种制备i型利托那韦多晶型结晶的方法
US9370578B2 (en) 2012-03-07 2016-06-21 Ratiopharm Gmbh Dosage form comprising lopinavir and ritonavir
EP2822553B1 (en) 2012-03-07 2016-05-18 ratiopharm GmbH Dosage form comprising non-crystalline lopinavir and crystalline ritonavir
CA2918707A1 (en) 2013-08-29 2015-03-05 Teva Pharmaceuticals Industries Ltd. Unit dosage form comprising emtricitabine, tenofovir, darunavir and ritonavir and a monolithic tablet comprising darunavir and ritonavir
EP3129009A1 (en) 2014-04-08 2017-02-15 Teva Pharmaceutical Industries Ltd Unit dosage form comprising emtricitabine, tenofovir, darunavir and ritonavir
CN106749085B (zh) * 2016-12-23 2019-05-24 东北制药集团股份有限公司 一种制备利托那韦的方法
EP3569225A1 (en) 2018-05-18 2019-11-20 Pharmaceutical Oriented Services Ltd Solid dispersion containing ritonavir
RU2759544C1 (ru) * 2021-01-29 2021-11-15 Общество с ограниченной ответственностью "АМЕДАРТ" Твёрдая фармацевтическая композиция для изготовления перорального терапевтического средства для профилактики и/или лечения ВИЧ-инфекции

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5354866A (en) 1989-05-23 1994-10-11 Abbott Laboratories Retroviral protease inhibiting compounds
US5696270A (en) 1989-05-23 1997-12-09 Abbott Laboratories Intermediate for making retroviral protease inhibiting compounds
PT727419E (pt) * 1992-12-29 2002-08-30 Abbott Lab Compostos intermediarios para a preparacao de inibidores da protease retroviral
IL110752A (en) 1993-09-13 2000-07-26 Abbott Lab Liquid semi-solid or solid pharmaceutical composition for an HIV protease inhibitor
US5559158A (en) 1993-10-01 1996-09-24 Abbott Laboratories Pharmaceutical composition
US5491253A (en) 1993-10-22 1996-02-13 Abbott Laboratories Process for the preparation of a substituted 2,5-diamino-3-hydroxyhexane
IL111991A (en) 1994-01-28 2000-07-26 Abbott Lab Liquid pharmaceutical composition of HIV protease inhibitors in organic solvent
US5567823A (en) * 1995-06-06 1996-10-22 Abbott Laboratories Process for the preparation of an HIV protease inhibiting compound
US6037157A (en) 1995-06-29 2000-03-14 Abbott Laboratories Method for improving pharmacokinetics
US6160122A (en) 1996-06-28 2000-12-12 Abbott Laboratories Process for the preparation of a disubstituted thiazole
ZA9710071B (en) 1996-11-21 1998-05-25 Abbott Lab Pharmaceutical composition.
MY145265A (en) * 1998-07-20 2012-01-13 Abbott Lab Amorphous ritonavir
DE19856432A1 (de) * 1998-12-08 2000-06-15 Basf Ag Nanopartikuläre Kern-Schale Systeme sowie deren Verwendung in pharmazeutischen und kosmetischen Zubereitungen
DK1183026T3 (da) * 1999-06-04 2006-11-06 Abbott Lab Forbedrede farmaceutiske formuleringer omfattende ritonavir

Also Published As

Publication number Publication date
EP2017269A3 (en) 2009-06-10
EP1418174B1 (en) 2009-03-18
SI1418174T1 (sl) 2009-08-31
KR100740796B1 (ko) 2007-07-20
TWI227713B (en) 2005-02-11
EP1418174A2 (en) 2004-05-12
HU227540B1 (en) 2011-08-29
NO20010298L (no) 2001-01-18
NZ522690A (en) 2004-04-30
PT1418174E (pt) 2009-06-08
CZ2006533A3 (cs) 2001-05-16
AU5003799A (en) 2000-02-07
PL213978B1 (pl) 2013-05-31
ATE425974T1 (de) 2009-04-15
CO5090830A1 (es) 2001-10-30
ATE261947T1 (de) 2004-04-15
TWI362382B (en) 2012-04-21
HK1121155A1 (en) 2009-04-17
ID27996A (id) 2001-05-03
KR20010072003A (ko) 2001-07-31
AU768207B2 (en) 2003-12-04
CY1111600T1 (el) 2015-10-07
KR100853371B1 (ko) 2008-08-22
CA2510949C (en) 2009-11-17
DE69915628T2 (de) 2004-08-12
HUP0103823A3 (en) 2003-05-28
CA2337846A1 (en) 2000-01-27
AR059763A2 (es) 2008-04-30
HU230150B1 (hu) 2015-09-28
NO20010298D0 (no) 2001-01-18
DK1418174T3 (da) 2009-05-18
IL140492A (en) 2010-12-30
CA2337846C (en) 2006-02-21
DE69940616D1 (de) 2009-04-30
EP2017269A9 (en) 2009-10-14
PT2017269E (pt) 2011-12-20
SK287381B6 (sk) 2010-08-09
ATE534636T1 (de) 2011-12-15
CZ298188B6 (cs) 2007-07-18
IL191582A (en) 2016-02-29
CN1310715A (zh) 2001-08-29
CA2510949A1 (en) 2000-01-27
PT1097148E (pt) 2004-05-31
ES2214038T3 (es) 2004-09-01
AR019431A1 (es) 2002-02-20
KR20040081137A (ko) 2004-09-20
IL187181A0 (en) 2008-02-09
CZ2001203A3 (en) 2001-05-16
BG105197A (en) 2001-10-31
MY121765A (en) 2006-02-28
EP2298751A2 (en) 2011-03-23
BG110080A (bg) 2008-11-28
EP2017269A2 (en) 2009-01-21
BG66140B1 (bg) 2011-07-29
IL191582A0 (en) 2008-12-29
CN102153524A (zh) 2011-08-17
IL187181A (en) 2009-09-01
AR059764A2 (es) 2008-04-30
CN101259128A (zh) 2008-09-10
NZ509125A (en) 2003-02-28
AR049658A2 (es) 2006-08-23
WO2000004016A3 (en) 2000-03-30
WO2000004016A2 (en) 2000-01-27
KR100793046B1 (ko) 2008-01-10
MY145265A (en) 2012-01-13
JP2017061475A (ja) 2017-03-30
PL348033A1 (en) 2002-05-06
DK1097148T3 (da) 2004-04-26
TWI271400B (en) 2007-01-21
DK2017269T3 (da) 2012-03-05
IL140492A0 (en) 2002-02-10
CA2674800A1 (en) 2000-01-27
BG65150B1 (bg) 2007-04-30
PL194710B1 (pl) 2007-06-29
SI2017269T1 (sl) 2012-02-29
BG65963B1 (bg) 2010-07-30
EP1418174A3 (en) 2004-06-23
TW200716550A (en) 2007-05-01
SK286388B6 (sk) 2008-09-05
EP2017269B1 (en) 2011-11-23
HU0800267D0 (en) 2008-06-30
JP2002520410A (ja) 2002-07-09
CN1502613A (zh) 2004-06-09
EP1097148B1 (en) 2004-03-17
SI1097148T1 (en) 2004-10-31
ES2322759T3 (es) 2009-06-26
SK922001A3 (en) 2001-07-10
ES2372990T3 (es) 2012-01-30
KR20060118022A (ko) 2006-11-17
EP2298751A3 (en) 2011-08-17
BG109682A (bg) 2007-03-30
CY1112139T1 (el) 2015-11-04
AR044029A2 (es) 2005-08-24
CN101966180A (zh) 2011-02-09
CZ307116B6 (cs) 2018-01-24
JP2010270135A (ja) 2010-12-02
TR200100171T2 (tr) 2001-05-21
JP5732212B2 (ja) 2015-06-10
DE69915628D1 (en) 2004-04-22
CN1310715B (zh) 2010-11-03
EP2017269A8 (en) 2009-09-30
EP1097148A2 (en) 2001-05-09
HUP0103823A2 (hu) 2002-02-28
HU229999B1 (en) 2015-04-28
JP2014074047A (ja) 2014-04-24
NO20042393L (no) 2001-01-18
NO318385B1 (no) 2005-03-14
BR9912010A (pt) 2001-04-10
JP4815050B2 (ja) 2011-11-16
NO327320B1 (no) 2009-06-08
SK287586B6 (sk) 2011-03-04
HK1037918A1 (en) 2002-02-22

Similar Documents

Publication Publication Date Title
HUP0100215A3 (en) Process for the preparation of substantially amorphous alpha-ol
HU9904445D0 (en) Aniline derivatives and process for the preparation of the same
HK1001618A1 (en) Novel pyrimidine derivatives and processes for the preparation thereof
HU0800266D0 (en) Amorphous ritonavir and process for the preparation of the polymorphous form i the same
HUP9900163A3 (en) Process for the preparation of sterol-and stanol-esters, and use thereof
IL137004A0 (en) Crystallographically stable amorphous cephalosporin compositions and process for producing the same
IL129759A0 (en) Process for the preparation of benzyl-ethers
AP2000002010A0 (en) Novel pharmaceutical compositions for treating and saving and the methods for the preparation thereof
CZ20012118A3 (cs) Způsob výroby 3-alkanoylindolu a 3-alkylindolu
IL129906A0 (en) Process for the preparation of beta-isophorone
HUP0101779A3 (en) Process for de-chlorinating and de-fouling waste-oil
GB2348642B (en) Process for the preparation of pyromellitic dianhydride
EP0990632A4 (en) ADAMANTANEMETHANOL DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF
ZA9711358B (en) Process for the preparation of thiazole derivatives
EP0890599A4 (en) POLYORGANOSILOXANES AND METHOD FOR THE PRODUCTION THEREOF
HUP0103128A3 (en) Process for the preparation of fluorobenzyl derivatives
IL130766A0 (en) Process for the preparation of thiazole derivatives
PL345166A1 (en) N-phenyl-n'-phenylpropylpiperazine derivatives and process for the preparation thereof
HUP0104544A2 (en) New pharmaceutical composition and the process for its preparation
GB9814869D0 (en) Process and composition
EP1016682A4 (en) TETRACYCLODODECES COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF
ZA200004376B (en) Process for the preparation of tetrapeptide
GR3035436T3 (en) Process for the preparation of 2-H-heptafluoropropane
IL128026A0 (en) Process for the preparation of hexanitrohexa-azaisowurtzitanes
AU2935699A (en) Process for the decoration of wall-tiles and floor-tiles

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: ABBVIE INC., US

Free format text: FORMER OWNER(S): ABBOTT LABORATORIES, US